Top Markets
#1 Siren Siren +38.34%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.79%
#3 RedStone RedStone +18.90%
#4 Verus Coin Verus Coin +18.06%
#5 Ocean Protocol Ocean Protocol +16.25%
#6 Cysic Cysic +15.47%
#7 OpenEden OpenEden +14.56%
#8 Perle Perle +14.21%
#9 Arowana Arowana +12.55%
#10 KUB Coin KUB Coin +12.53%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Rank in Stocks #32145
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Share Price
$1.49
Last synced: 2026-08-17
Market Cap
$10.94M
Change (1 day)
4.58%
Change (1 year)
-55.67%
Country
US
Trade Ainos, Inc. (AIMD)

Category

Healthcare
Number of shares outstanding for Ainos, Inc. (AIMD)
Number of shares outstanding as of August 2026: 0
According to Ainos, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Ainos, Inc. (AIMD) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR